A history of the development of Covid treatment protocols including Ivermectin

Dr. Pierre Kory outlines the History of FLCCC Recommendations in this medical lecture that he delivered via Zoom on July 24, 2021, to the physicians and citizens of Malaysia upon his receiving the Benevolence Leadership Award from the Cheng Ho Multi Culture Education Trust and Tan Sri Lee Kim Yew of Malaysia.

In it, he tells the story of how and why the FLCCC Alliance was formed—and how, at the start of the pandemic, the team quickly began to develop protocols to successfully treat patients. Their first, the MATH+ Hospital Treatment Protocol, was used to save critically ill patients and to prevent them from having to rely on ventilators to breathe. As COVID-19 cases surged, they urgently researched ways to offload the hospitals and reduce case counts and deaths. Their I-MASK+ Prevention & Early Outpatient Treatment Protocol centered around the drug ivermectin—which is effective for prevention as well as treating early and late phases of COVID-19. Treatment for Long Haul COVID disease followed. (Runs 39 minutes).

Original here.